Cencora (0HF3) Share Forecast & Price Target

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0HF3 Analyst Ratings

Strong Buy

9 Buy

3 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Cencora

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0HF3 Stock 12 Month Forecast

Average Price Target

$369.18

▲(18.43% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Cencora in the last 3 months. The average price target is $369.18 with a high forecast of $430.00 and a low forecast of $330.00. The average price target represents a 18.43% change from the last price of $311.72.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"264":"$264","431":"$431","305.75":"$305.8","347.5":"$347.5","389.25":"$389.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":430,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$430.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":369.1818181818182,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$369.18</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":330,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$330.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[264,305.75,347.5,389.25,431],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,311.574,320.6836923076923,329.79338461538464,338.9030769230769,348.0127692307692,357.12246153846155,366.23215384615384,375.3418461538462,384.45153846153846,393.56123076923075,402.6709230769231,411.7806153846154,420.8903076923077,{"y":430,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,311.574,316.00537062937065,320.4367412587413,324.8681118881119,329.29948251748255,333.7308531468532,338.16222377622375,342.5935944055944,347.024965034965,351.45633566433565,355.8877062937063,360.3190769230769,364.75044755244755,{"y":369.1818181818182,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,311.574,312.9913846153846,314.4087692307692,315.82615384615383,317.2435384615385,318.6609230769231,320.0783076923077,321.4956923076923,322.9130769230769,324.3304615384615,325.7478461538462,327.1652307692308,328.5826153846154,{"y":330,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":286.514,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":287.608,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":311.054,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":335.669,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":360.622,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":338.359,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":360.211,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":368.086,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":316.971,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":303.696,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":265.461,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":286.412,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":311.574,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$430.00

Average Price Target$369.18

Lowest Price Target$330.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ryan Halsted

RBC Capital

$330

Hold

5.86%

Upside

Initiated

08/19/26

Cencora initiated with a Sector Perform at RBC CapitalCencora initiated with a Sector Perform at RBC Capital

Elizabeth Anderson CFA

Evercore ISI

$350

Buy

12.28%

Upside

Reiterated

08/13/26

Cencora (COR) Gets a Buy from Evercore ISI

Glen Santangelo

Barclays

$350

Buy

12.28%

Upside

Reiterated

08/13/26

Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Cencora (COR)

Allen Lutz

Bank of America Securities

$310→$330

Hold

5.86%

Upside

Reiterated

08/12/26

Bank of America Securities Remains a Hold on Cencora (COR)

Stephen Baxter

Wells Fargo

$331→$395

Buy

26.72%

Upside

Assigned

08/11/26

Wells Fargo Gives a Buy Rating to Cencora (COR)

Lisa Gill

J.P. Morgan

$390

Buy

25.11%

Upside

Reiterated

08/10/26

J.P. Morgan Sticks to Their Buy Rating for Cencora (COR)

Charles Rhyee

TD Cowen

$400

Buy

28.32%

Upside

Reiterated

08/09/26

Cencora: Strong U.S. Health Care Momentum and Solid Long‑Term EPS Outlook Underpin Buy Rating

Erin Wright

Morgan Stanley

$342→$346

Buy

11.00%

Upside

Assigned

08/07/26

Cencora (COR) Gets a Buy from Morgan Stanley

Eric Coldwell

Robert W. Baird

$340→$370

Buy

18.70%

Upside

Reiterated

08/06/26

Cencora price target raised to $370 from $340 at BairdCencora price target raised to $370 from $340 at Baird

Kevin Caliendo

UBS

$412→$430

Buy

37.94%

Upside

Reiterated

08/06/26

UBS Reaffirms Their Buy Rating on Cencora (COR)

Daniel Grosslight

Citi

$355→$370

Buy

18.70%

Upside

Reiterated

08/06/26

Cencora price target raised to $370 from $355 at CitiCencora price target raised to $370 from $355 at Citi

Ryan Daniels

William Blair

―

Hold

―

Reiterated

08/05/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cencora (NYSE: COR), American Well (NYSE: AMWL) and BeOne Medicines (NASDAQ: ONC)

David Toung

Argus Research

$400

Buy

28.32%

Upside

Reiterated

03/17/26

Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NYSE: NUVB) and Cencora (NYSE: COR)

Brian Tanquilut

Jefferies

$330→$440

Buy

41.15%

Upside

Upgraded

01/22/26

Cencora upgraded to Buy from Hold at JefferiesCencora upgraded to Buy from Hold at Jefferies

George Hill

Deutsche Bank

$322→$371

Buy

19.02%

Upside

Reiterated

11/07/25

Cencora price target raised to $371 from $322 at Deutsche BankCencora price target raised to $371 from $322 at Deutsche Bank

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ryan Halsted

RBC Capital

$330

Hold

5.86%

Upside

Initiated

08/19/26

Cencora initiated with a Sector Perform at RBC CapitalCencora initiated with a Sector Perform at RBC Capital

Elizabeth Anderson CFA

Evercore ISI

$350

Buy

12.28%

Upside

Reiterated

08/13/26

Cencora (COR) Gets a Buy from Evercore ISI

Glen Santangelo

Barclays

$350

Buy

12.28%

Upside

Reiterated

08/13/26

Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Cencora (COR)

Allen Lutz

Bank of America Securities

$310→$330

Hold

5.86%

Upside

Reiterated

08/12/26

Bank of America Securities Remains a Hold on Cencora (COR)

Stephen Baxter

Wells Fargo

$331→$395

Buy

26.72%

Upside

Assigned

08/11/26

Wells Fargo Gives a Buy Rating to Cencora (COR)

Lisa Gill

J.P. Morgan

$390

Buy

25.11%

Upside

Reiterated

08/10/26

J.P. Morgan Sticks to Their Buy Rating for Cencora (COR)

Charles Rhyee

TD Cowen

$400

Buy

28.32%

Upside

Reiterated

08/09/26

Cencora: Strong U.S. Health Care Momentum and Solid Long‑Term EPS Outlook Underpin Buy Rating

Erin Wright

Morgan Stanley

$342→$346

Buy

11.00%

Upside

Assigned

08/07/26

Cencora (COR) Gets a Buy from Morgan Stanley

Eric Coldwell

Robert W. Baird

$340→$370

Buy

18.70%

Upside

Reiterated

08/06/26

Cencora price target raised to $370 from $340 at BairdCencora price target raised to $370 from $340 at Baird

Kevin Caliendo

UBS

$412→$430

Buy

37.94%

Upside

Reiterated

08/06/26

UBS Reaffirms Their Buy Rating on Cencora (COR)

Daniel Grosslight

Citi

$355→$370

Buy

18.70%

Upside

Reiterated

08/06/26

Cencora price target raised to $370 from $355 at CitiCencora price target raised to $370 from $355 at Citi

Ryan Daniels

William Blair

―

Hold

―

Reiterated

08/05/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cencora (NYSE: COR), American Well (NYSE: AMWL) and BeOne Medicines (NASDAQ: ONC)

David Toung

Argus Research

$400

Buy

28.32%

Upside

Reiterated

03/17/26

Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NYSE: NUVB) and Cencora (NYSE: COR)

Brian Tanquilut

Jefferies

$330→$440

Buy

41.15%

Upside

Upgraded

01/22/26

Cencora upgraded to Buy from Hold at JefferiesCencora upgraded to Buy from Hold at Jefferies

George Hill

Deutsche Bank

$322→$371

Buy

19.02%

Upside

Reiterated

11/07/25

Cencora price target raised to $371 from $322 at Deutsche BankCencora price target raised to $371 from $322 at Deutsche Bank

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ODTXOdyssey Therapeutics, Inc.

BTSGBrightSpring Health Services, Inc.

GPCRStructure Therapeutics, Inc. Sponsored ADR

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cencora

3 Months

Charles RhyeeTD Cowen

Success Rate

28/40 ratings generated profit

Average Return

+5.88%

Copying Charles Rhyee's trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +5.88% per trade.

1 Year

David ToungArgus Research

Success Rate

15/17 ratings generated profit

Average Return

+19.18%

Copying David Toung's trades and holding each position for 1 Year would result in 88.24% of your transactions generating a profit, with an average return of +19.18% per trade.

2 Years

Charles RhyeeTD Cowen

Success Rate

37/40 ratings generated profit

Average Return

+36.11%

Copying Charles Rhyee's trades and holding each position for 2 Years would result in 92.50% of your transactions generating a profit, with an average return of +36.11% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0HF3 Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0HF3 has received 13 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. 0HF3 average Analyst price target in the past 3 months is 369.18.

Each month's total comprises the sum of three months' worth of ratings.

0HF3 Financial Forecast

0HF3 Earnings Forecast

Next quarter’s earnings estimate for 0HF3 is $4.56 with a range of $4.48 to $4.62. The previous quarter’s EPS was $4.48. 0HF3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0HF3 has Performed in-line its overall industry.

0HF3 Sales Forecast

Next quarter’s sales forecast for 0HF3 is $88.14B with a range of $86.69B to $89.99B. The previous quarter’s sales results were $84.75B. 0HF3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0HF3 has Performed in-line its overall industry.

0HF3 Stock Forecast FAQ

What is GB:0HF3’s average 12-month price target, according to analysts?

Based on analyst ratings, Cencora’s 12-month average price target is 369.18.

What is GB:0HF3’s upside potential, based on the analysts’ average price target?

Cencora has 18.43% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Cencora a Buy, Sell or Hold?

Cencora has a consensus rating of Strong Buy, which is based on 9 buy ratings, 3 hold ratings and 0 sell ratings.

What is Cencora’s share price target?

The average share price target for Cencora is 369.18. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $430.00 ,and the lowest forecast is $330.00. The average share price target represents 18.43% Increase from the current price of $311.72.

What do analysts say about Cencora?

Cencora’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of Cencora?

To buy shares of GB:0HF3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Cencora (0HF3) Share Forecast & Price Target

0HF3 Analyst Ratings

0HF3 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cencora

0HF3 Analyst Recommendation Trends

0HF3 Financial Forecast

0HF3 Earnings Forecast

0HF3 Sales Forecast

0HF3 Stock Forecast FAQ

Detailed List of Analyst Forecasts